Clene Inc.
CLNNNasdaqCIK 1822791HealthcareFiscal year ends Dec 31
Reports and events: 171 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2023:37 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-032960 |
| 2026-10-1912:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032882 |
| 2026-09-1621:13 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-030581 |
| 2026-08-1412:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027837 |
| 2026-08-1412:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027828 |
| 2026-08-1012:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-026653 |
| 2026-05-2220:37 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-018267 |
| 2026-05-1412:02 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016881 |
| 2026-05-1411:54 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016878 |
| 2026-05-0521:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014946 |
| 2026-05-0412:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014542 |
| 2026-04-1020:05 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001437749-26-012018 |
| 2026-03-1711:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-008502 |
| 2026-03-1722:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-008482 |
| 2026-03-1212:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-007828 |
| 2026-02-2413:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-005156 |
| 2026-01-1321:36 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-001196 |
| 2026-01-1213:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-001049 |
| 2025-12-0313:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-036713 |
| 2025-12-0313:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-036712 |
| 2025-11-1313:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034621 |
| 2025-11-1312:51 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034613 |
| 2025-10-1720:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-031277 |
| 2025-10-1412:00 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-030891 |
| 2025-09-2512:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-029846 |
| 2025-09-0520:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-028485 |
| 2025-08-1412:41 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-25-026690 |
| 2025-08-1412:02 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001437749-25-026679 |
| 2025-07-0320:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-022150 |
| 2025-06-3012:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-021483 |
| 2025-06-1720:31 ET | 8-K | 8.01 Other events | 0001437749-25-020669 |
| 2025-05-2320:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-018336 |
| 2025-05-0712:03 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001437749-25-014918 |
| 2025-05-0712:02 ET | 8-K | 2.02 Results of operations; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-25-014917 |
| 2025-04-2811:58 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-013230 |
| 2025-04-0820:08 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001437749-25-011400 |
| 2025-04-0812:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-011309 |
| 2025-03-2712:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-009484 |
| 2025-03-2420:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001437749-25-008956 |
| 2025-03-2413:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-008869 |
| 2025-03-1212:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-007120 |
| 2025-01-3021:31 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-002265 |
| 2024-12-2022:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-038152 |
| 2024-12-1013:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-037061 |
| 2024-11-1313:05 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-034668 |
| 2024-11-1312:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001437749-24-034663 |
| 2024-10-2312:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-031805 |
| 2024-10-0220:38 ET | SC 13D/A | Ownership report, active investor, amended | 0000897069-24-001916 |
| 2024-09-3021:11 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-24-030269 |
| 2024-09-3020:45 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-030263 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.